These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28946553

  • 1. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 2. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019 Dec 06; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 3. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Dec 06; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 4. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 5. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
    Li HY, Li YM, Li Y, Shi XW, Chen H.
    Eur Rev Med Pharmacol Sci; 2016 Sep 30; 20(17):3599-604. PubMed ID: 27649660
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 30; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 7. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X.
    Cell Oncol (Dordr); 2018 Feb 30; 41(1):25-33. PubMed ID: 29076027
    [Abstract] [Full Text] [Related]

  • 8. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A.
    Clin Neurol Neurosurg; 2020 Mar 30; 190():105652. PubMed ID: 31896490
    [Abstract] [Full Text] [Related]

  • 9. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
    Cheng ZX, Song YX, Wang ZY, Wang Y, Dong Y.
    Eur Rev Med Pharmacol Sci; 2017 Sep 30; 21(18):4079-4086. PubMed ID: 29028093
    [Abstract] [Full Text] [Related]

  • 10. MiR-106a is an independent prognostic marker in patients with glioblastoma.
    Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, Hou X, Wang C, Wu J, Liu H, Wang L, Zhang G, Qi J, Fang X, Shi C, Ai J.
    Neuro Oncol; 2013 Jun 30; 15(6):707-17. PubMed ID: 23416698
    [Abstract] [Full Text] [Related]

  • 11. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK, Pastori C, Penas C, Komotar RJ, Ivan ME, Wahlestedt C, Ayad NG.
    Mol Cancer; 2018 Mar 20; 17(1):74. PubMed ID: 29558959
    [Abstract] [Full Text] [Related]

  • 12. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M, Ezz El Arab L, Al-Posttany AS, B Said S.
    J Neurooncol; 2019 Sep 20; 144(3):545-551. PubMed ID: 31422498
    [Abstract] [Full Text] [Related]

  • 13. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y, Alivand M, Mollanoori H.
    Comput Biol Chem; 2021 Jun 20; 92():107458. PubMed ID: 33761401
    [Abstract] [Full Text] [Related]

  • 14. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
    Yerukala Sathipati S, Huang HL, Ho SY.
    BMC Genomics; 2016 Dec 22; 17(Suppl 13):1022. PubMed ID: 28155650
    [Abstract] [Full Text] [Related]

  • 15. Serum microRNA profiling in patients with glioblastoma: a survival analysis.
    Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB.
    Mol Cancer; 2017 Mar 11; 16(1):59. PubMed ID: 28284220
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y.
    Int J Clin Exp Pathol; 2015 Mar 11; 8(1):727-34. PubMed ID: 25755767
    [Abstract] [Full Text] [Related]

  • 17. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
    Yuan GQ, Wei NL, Mu LY, Wang XQ, Zhang YN, Zhou WN, Pan YW.
    Cancer Biomark; 2017 Dec 06; 20(4):443-452. PubMed ID: 28869437
    [Abstract] [Full Text] [Related]

  • 18. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
    Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y.
    J Transl Med; 2013 Jan 09; 11():10. PubMed ID: 23302469
    [Abstract] [Full Text] [Related]

  • 19. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y, Chen C, Yu SZ, Liu Q, Rao J, Zhang HR, Xiao HL, Fu TW, Long H, He ZC, Zhou K, Yao XH, Cui YH, Zhang X, Ping YF, Bian XW.
    Clin Cancer Res; 2015 Sep 01; 21(17):4004-13. PubMed ID: 26023083
    [Abstract] [Full Text] [Related]

  • 20. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct 01; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.